3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
3
Ovarian Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Solid Tumor, Unspecified, Adult
1
Solid Tumor
1
Prostatic Neoplasms
1
Metastatic Castration Resistant Prostate Cancer
1
Genital Neoplasms, Female
1
Fallopian Tube Neoplasms
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Interventions
enzalutamide
4
rucaparib
1
abiraterone
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Metastatic Castration Resistant Prostate Cancer
×
rucaparib
×
Clear all
NCT04179396
2023-06-29
RAMP
pharmaand GmbH
Phase 1
Completed
8 enrolled
8 charts